Company intelligence / Profile preview

PharmaPlot

Glyka Nera, Sterea Ellada, Greecepharmaplot.com ↗

Ownership: Private
Development stage: Commercial

Overview

PharmaPlot develops, out-licenses, and supplies high-quality generic pharmaceutical products and value-added medicines. The company offers a robust supply chain covering all stages from product development to regulatory approval and life cycle management. Its portfolio includes solid dosage forms (tablets & capsules), injectables, oral solutions, and suspensions suitable for Day 1 launch upon patent expiry. Products are intended for commercialization in Europe and globally.

Modalities: Small molecule (generic drugs in solid dosage, injectables, oral solutions)
Industry: Biotech

Beyond the preview

Go deeper on PharmaPlot.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmaPlot.

Explore the full profile